Nov 20
Lunchtime panel discussion at the 109th Session of the IOM Council - 'Advancing the migration health research agenda for evidence-informed policy and practice'.
MHADRI interns - Holly McCarthy and Pearl Agbenyezi - are working with MHADRI members and other migration and health researchers to explore gaps in migration and health research globally.
ISTM has opened the call for Research Award proposals to non-ISTM members who reside in countries identified by the World Bank as low income and low-middle income. We are committed to foster and support research in areas of the world where opportunities are otherwise limited.
A call for papers for a Special Issue on "The World in Crisis: Current Health Issues" in the International Journal of Environmental Research and Public Health. The venue is a peer-reviewed scientific journal that publishes articles and communications in the interdisciplinary area of environmental health sciences and public health.
The International Consultation on Pre-departure Health Assessments was held from 26th to 27th September 2017. Hosted by the Sri Lanka Ministry of Health with assistance from IOM, this successful event was attended by more than 80 academics, government representatives, and medical officers.
Access of refugees and migrants to health services is often framed within a human rights’ discourse. The right to the highest sustainable standard of health is recognised in the UN International Covenant on Economic, Social and Cultural Rights, and in other international treaties and conventions. The importance of health and well-being are also shown by the central place they hold within the Sustainable Development Goals (SGDs) - SDG Goal 3, Ensure healthy lives and promote well-being for all at all ages. When it comes to refugees and migrants, two pivotal documents are the World Health Assembly Resolutions 61.17 and 70.15, which urge the Member States to consider promoting the framework of priorities and guiding principles to promote the health of refugees and migrants. A WHO global action plan to promote the health of refugees and migrants is currently being developed in consultation with the countries.
Dr. Marcelo Urquia at the Manitoba Centre for Health Policy (MCHP), University of
Manitoba invites applications for a post-doctoral fellowship in the Epidemiology of Migration and Health. The successful applicant will join a Canadian Institutes of Health Research (CIHR)-funded large multidisciplinary team of accomplished researchers,
clinicians, policy makers and community partners in Manitoba, Ontario and rest of Canada, with an interest in studying the health and wellbeing of immigrants to Canada (and other vulnerable populations) using a global gender-based framework.
The specific challenges we have encountered in our fieldwork in migration contexts highlight the need for better evidence to improve health-system responses to migration, mobility, and health. We have identified five core areas in which action is needed to support the development of a global research agenda on migration, mobility, and health.
Migration impacts the South African public healthcare system but not in the ways
often assumed, and sectors responsible for improving responses have a poor
understanding of migration. The need for better data is emphasised, existing policy
responses are outlined, and strategic opportunities for intervention are suggested.
Recommendations are made for migration-aware health systems that embed
population movement as central to the design of health interventions, policy, and
research. Such responses offer strategic opportunities to address health inequity, both
nationally and regionally, with resulting health and developmental benefits for all.
Testing refugees in an overseas setting through a systematic HA identified patients with a range of infectious diseases. Our results reflect similar patterns found in other programmes and indicate that the yields for infectious diseases vary by region and nationality. This information may help in designing a more targeted approach to testing, which has already started in the UK programme. Further work is needed to refine how best to identify infections in refugees, taking these factors into account.
Healthcare practitioners who are dedicated to making the lives of children and their families better watched in disbelief as the ongoing situation of separating children from their parents unfolded at the southern border of the United States. We know that for many families the migration journey is traumatic and has lasting effects; separation and detention simply compound this trauma.
The conditions in which migrants travel, live, and work often carry exceptional risks to their physical and mental well-being. Even if certain migrant groups have access to health services, they tend to avoid them due to fear of deportation, xenophobic and discriminatory attitudes within society, and other linguistic, cultural, and economic barriers. Evidence indicates that social stigmatization and anxieties generated by restrictive immigration policies hinder undocumented immigrants’ access to health rights and minimizes immigrants’ sense of entitlement to such rights.
The European Centre for Disease Prevention and Control is developing evidence-based guidance for voluntary screening, treatment and vaccine prevention of infectious diseases for newly arriving migrants to the European Union/European Economic Area. The objective of this systematic review protocol is to guide the identification, appraisal and synthesis of the best available evidence on prevention and assessment of the following priority infectious diseases: tuberculosis, HIV, hepatitis B, hepatitis C, measles, mumps, rubella, diphtheria, tetanus, pertussis, poliomyelitis (polio), Haemophilus influenza disease, strongyloidiasis and schistosomiasis.
Australia, Canada, New Zealand, the United Kingdom, and the United States are the largest immigrant- and refugee-receiving countries in the world and are currently collaborating on preventing importation of TB into each of their countries. Joint efforts in a small number of high-burden countries can help prevent importation of TB cases and also contribute to control efforts within source countries.
This article first sets out general principles for cross-border collaboration and continuity of care. It then presents a series of case studies. Policies and practices on cross-border collaboration in selected low-incidence countries (Australia, Italy, Norway, The Netherlands, the United Kingdom and the United States) are described and critically appraised. Details of the World Health Organization's (WHO's) European Respiratory Society TB Consilium for transborder migration and those of the Health Network's TBNet activities are described. With increasing population movement, including migrants and travellers, it is time to build on good practices and existing tools and to remove legal, financial and social barriers to ensure early diagnosis, full treatment and continuity of care across our world.
